↓ Skip to main content

Liver Damage Associated with Minocycline Use in Acne

Overview of attention for article published in Drug Safety, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
1 policy source
patent
7 patents
facebook
1 Facebook page

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
28 Mendeley
Title
Liver Damage Associated with Minocycline Use in Acne
Published in
Drug Safety, November 2012
DOI 10.2165/00002018-200023040-00006
Pubmed ID
Authors

Ross A. Lawrenson, Helen E. Seaman, Anders Sundström, Timothy J. Williams, Richard D.T. Farmer

Abstract

Minocycline is an antibacterial drug used in the treatment of acne. Concern has been expressed over the possibility of severe adverse reactions to minocycline, including hepatitis. This study set out to identify and characterise reported cases of hepatotoxicity associated with the use of minocycline.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 7%
Unknown 26 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 21%
Researcher 4 14%
Student > Bachelor 3 11%
Student > Postgraduate 3 11%
Lecturer > Senior Lecturer 2 7%
Other 5 18%
Unknown 5 18%
Readers by discipline Count As %
Medicine and Dentistry 8 29%
Agricultural and Biological Sciences 6 21%
Pharmacology, Toxicology and Pharmaceutical Science 3 11%
Psychology 2 7%
Computer Science 1 4%
Other 1 4%
Unknown 7 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2017.
All research outputs
#5,339,368
of 25,374,647 outputs
Outputs from Drug Safety
#580
of 1,852 outputs
Outputs of similar age
#50,837
of 285,367 outputs
Outputs of similar age from Drug Safety
#218
of 812 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,367 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.